DE1458545U - - Google Patents

Info

Publication number
DE1458545U
DE1458545U DENDAT1458545D DE1458545DU DE1458545U DE 1458545 U DE1458545 U DE 1458545U DE NDAT1458545 D DENDAT1458545 D DE NDAT1458545D DE 1458545D U DE1458545D U DE 1458545DU DE 1458545 U DE1458545 U DE 1458545U
Authority
DE
Germany
Prior art keywords
zehälr
xoohen
wtä
wipd
wauaer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1458545D
Other languages
German (de)
English (en)
Publication of DE1458545U publication Critical patent/DE1458545U/de
Active legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1458545D Active DE1458545U (enExample)

Publications (1)

Publication Number Publication Date
DE1458545U true DE1458545U (enExample)

Family

ID=765665

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1458545D Active DE1458545U (enExample)

Country Status (1)

Country Link
DE (1) DE1458545U (enExample)

Similar Documents

Publication Publication Date Title
DE1458545U (enExample)
Halestrap Stimulation of pyruvate transport in metabolizing mitochondria through changes in the transmembrane pH gradient induced by glucagon treatment of rats
US8436031B2 (en) Transcription factor modulating compounds and methods of use thereof
Elmer et al. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients
Hashem et al. Approximating a function and its derivatives using MSE-optimal linear combinations of trained feedforward neural networks
WO2002083106A1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
US20050124678A1 (en) Transcription factor modulating compounds and methods of use thereof
US10696620B2 (en) Antimicrobial compounds
HK1004327A1 (en) Stable extended release oral dosage composition
Kutzer et al. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial
Mendling et al. Clinical effects of nifuratel in vulvovaginal infections
Prisant et al. Nifedipine GITS (gastrointestinal therapeutic system) bezoar
Miceli-Richard et al. NSAIDs in ankylosing spondylitis
Berlin et al. High circulating levels of 25-hydroxyvitamin D3 in renal stone formers with hyperabsorptive hypercalciuria
Gagné et al. Predicting the toxicity of complex mixtures using artificial neural networks
US20220125863A1 (en) Compositions for treating candidiasis infections
Nieskens et al. Vaginal Tritrichomonas foetus infection in mice as an in vivo model for drug development against Trichomonas vaginalis
McMAHON et al. The relationship between cytoplasmic free Ca2+ and the release of glutamate from synaptosomes
DE2932691A1 (de) Antimykotische mittel mit hoeherer freisetzung der wirkstoffe
Serkov et al. New Adamantane Derivatives with NO-Generating Fragment
MURAT POLICJANCI Z POLICJI PAŃSTWOWEJ W SZEREGACH MILICJIOBYWATELSKIEJ
La Rocca et al. Skin and mucous membrane ulceration in beagle dogs following oral dosing with an experimental aminoglycoside antibiotic
Karnik et al. Somatostatin inhibition of gastrin gene expression: involvement of pertussis toxin-sensitive and-insensitive pathways
Rajapbayevna TA’LIM TIZIMIDA GENDER PARADIGMALARINING ASOSIY XUSUSIYATLARI
World Health Organization HUMAN PLAGUE SURVEILLANCE= SURVEILLANCE DE LA PESTE HUMAINE